 Neelanjan Mukherjee
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 13 | 2023 | 422 | 2.250 |
Why?
| | RNA, Messenger | 16 | 2025 | 2833 | 1.690 |
Why?
| | RNA | 8 | 2023 | 921 | 1.490 |
Why?
| | Transcriptome | 7 | 2021 | 971 | 1.080 |
Why?
| | Polyadenylation | 3 | 2024 | 42 | 0.930 |
Why?
| | Pteridines | 1 | 2023 | 20 | 0.820 |
Why?
| | Gene Expression Regulation | 8 | 2025 | 2607 | 0.820 |
Why?
| | Aldehydes | 1 | 2023 | 145 | 0.770 |
Why?
| | Aldosterone | 1 | 2021 | 45 | 0.730 |
Why?
| | Evolution, Molecular | 3 | 2024 | 493 | 0.720 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 143 | 0.690 |
Why?
| | RNA, Ribosomal | 1 | 2021 | 168 | 0.680 |
Why?
| | Ribonucleoproteins | 3 | 2019 | 105 | 0.650 |
Why?
| | ELAV-Like Protein 1 | 6 | 2021 | 16 | 0.600 |
Why?
| | Antigens, Surface | 3 | 2011 | 154 | 0.500 |
Why?
| | HEK293 Cells | 8 | 2019 | 730 | 0.490 |
Why?
| | RNA, Untranslated | 1 | 2016 | 124 | 0.470 |
Why?
| | Tristetraprolin | 1 | 2014 | 8 | 0.430 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 2011 | 92 | 0.420 |
Why?
| | Gene Expression Profiling | 5 | 2016 | 1774 | 0.400 |
Why?
| | Sequence Analysis, RNA | 6 | 2019 | 452 | 0.390 |
Why?
| | Ribosomes | 3 | 2025 | 186 | 0.390 |
Why?
| | Open Reading Frames | 3 | 2025 | 123 | 0.390 |
Why?
| | RNA Stability | 1 | 2011 | 117 | 0.330 |
Why?
| | Binding Sites | 6 | 2019 | 1303 | 0.330 |
Why?
| | RNA Precursors | 1 | 2011 | 154 | 0.330 |
Why?
| | MicroRNAs | 6 | 2019 | 692 | 0.290 |
Why?
| | Proteogenomics | 1 | 2025 | 6 | 0.250 |
Why?
| | Computational Biology | 4 | 2018 | 644 | 0.240 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1142 | 0.230 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2025 | 16 | 0.230 |
Why?
| | Estrous Cycle | 1 | 2025 | 20 | 0.230 |
Why?
| | Codon, Nonsense | 1 | 2025 | 44 | 0.230 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2024 | 22 | 0.230 |
Why?
| | Poly A | 1 | 2024 | 51 | 0.220 |
Why?
| | Giardia lamblia | 1 | 2024 | 23 | 0.220 |
Why?
| | Ovary | 2 | 2025 | 221 | 0.220 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 305 | 0.220 |
Why?
| | Antigen Presentation | 1 | 2025 | 218 | 0.220 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2024 | 44 | 0.220 |
Why?
| | HLA Antigens | 1 | 2025 | 240 | 0.220 |
Why?
| | Immunoprecipitation | 3 | 2014 | 155 | 0.220 |
Why?
| | Eukaryota | 1 | 2024 | 57 | 0.220 |
Why?
| | T-Lymphocytes | 2 | 2009 | 1996 | 0.210 |
Why?
| | Endosomes | 1 | 2024 | 136 | 0.210 |
Why?
| | Follicle Stimulating Hormone | 1 | 2025 | 244 | 0.210 |
Why?
| | ELAV Proteins | 3 | 2011 | 14 | 0.190 |
Why?
| | Multiple Myeloma | 1 | 2025 | 252 | 0.190 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2025 | 412 | 0.190 |
Why?
| | 3' Untranslated Regions | 2 | 2021 | 145 | 0.190 |
Why?
| | Argonaute Proteins | 2 | 2019 | 27 | 0.180 |
Why?
| | Angiotensin II | 1 | 2021 | 99 | 0.180 |
Why?
| | Insulin-Secreting Cells | 1 | 2025 | 377 | 0.180 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2025 | 801 | 0.170 |
Why?
| | Protein Biosynthesis | 4 | 2025 | 433 | 0.170 |
Why?
| | Phylogeny | 1 | 2024 | 904 | 0.170 |
Why?
| | Molecular Sequence Annotation | 2 | 2019 | 99 | 0.170 |
Why?
| | Humans | 26 | 2025 | 137585 | 0.160 |
Why?
| | Software | 3 | 2018 | 665 | 0.160 |
Why?
| | Interferons | 1 | 2021 | 202 | 0.160 |
Why?
| | Herpesvirus 8, Human | 2 | 2011 | 65 | 0.160 |
Why?
| | Peptides | 1 | 2025 | 985 | 0.150 |
Why?
| | Hydrocortisone | 1 | 2021 | 322 | 0.150 |
Why?
| | Base Sequence | 3 | 2019 | 2181 | 0.150 |
Why?
| | Nucleotide Motifs | 1 | 2018 | 35 | 0.150 |
Why?
| | Drosophila melanogaster | 2 | 2019 | 233 | 0.150 |
Why?
| | Proteome | 1 | 2023 | 472 | 0.150 |
Why?
| | Gene Expression | 2 | 2016 | 1502 | 0.150 |
Why?
| | RNA Splicing | 2 | 2017 | 269 | 0.150 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 591 | 0.140 |
Why?
| | RNA, Antisense | 2 | 2019 | 17 | 0.140 |
Why?
| | Signal Transduction | 4 | 2024 | 5079 | 0.130 |
Why?
| | Drosophila Proteins | 1 | 2019 | 204 | 0.130 |
Why?
| | RNA, Long Noncoding | 1 | 2019 | 181 | 0.130 |
Why?
| | DEAD-box RNA Helicases | 1 | 2017 | 76 | 0.130 |
Why?
| | RNA, Viral | 2 | 2011 | 656 | 0.120 |
Why?
| | Cells, Cultured | 2 | 2021 | 4193 | 0.120 |
Why?
| | Neoplasm Proteins | 2 | 2017 | 434 | 0.120 |
Why?
| | Phenotype | 1 | 2023 | 3196 | 0.110 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 622 | 0.110 |
Why?
| | DNA Damage | 1 | 2017 | 420 | 0.110 |
Why?
| | RNA, Plant | 1 | 2013 | 9 | 0.100 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 150 | 0.100 |
Why?
| | Genome, Human | 1 | 2016 | 425 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2010 | 767 | 0.100 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2012 | 19 | 0.100 |
Why?
| | Protein Interaction Mapping | 1 | 2013 | 109 | 0.100 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2012 | 50 | 0.100 |
Why?
| | Arabidopsis | 1 | 2013 | 95 | 0.100 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 3412 | 0.090 |
Why?
| | Lymphoma, Primary Effusion | 1 | 2011 | 4 | 0.090 |
Why?
| | Mice | 9 | 2025 | 17787 | 0.090 |
Why?
| | Transcription, Genetic | 2 | 2019 | 1457 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1396 | 0.090 |
Why?
| | Amino Acid Motifs | 1 | 2011 | 225 | 0.090 |
Why?
| | Nuclear Factor 90 Proteins | 1 | 2010 | 1 | 0.090 |
Why?
| | Animals | 13 | 2025 | 36940 | 0.080 |
Why?
| | Nanoparticles | 1 | 2016 | 481 | 0.080 |
Why?
| | Ovarian Neoplasms | 1 | 2016 | 565 | 0.080 |
Why?
| | Poly(A)-Binding Proteins | 1 | 2009 | 4 | 0.080 |
Why?
| | Stilbenes | 1 | 2009 | 35 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2009 | 134 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2016 | 2475 | 0.070 |
Why?
| | Thymus Gland | 1 | 2009 | 312 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2007 | 155 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2024 | 366 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1670 | 0.060 |
Why?
| | Peptide Chain Termination, Translational | 1 | 2025 | 9 | 0.060 |
Why?
| | rho GTP-Binding Proteins | 1 | 2006 | 60 | 0.060 |
Why?
| | Codon, Terminator | 1 | 2025 | 25 | 0.060 |
Why?
| | Algorithms | 1 | 2013 | 1704 | 0.060 |
Why?
| | Radiation Tolerance | 1 | 2006 | 96 | 0.060 |
Why?
| | Follicle Stimulating Hormone, beta Subunit | 1 | 2025 | 31 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2017 | 2253 | 0.060 |
Why?
| | Adenoviridae | 1 | 2005 | 193 | 0.060 |
Why?
| | Paclitaxel | 1 | 2005 | 230 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2006 | 510 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2900 | 0.050 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2005 | 191 | 0.050 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 196 | 0.050 |
Why?
| | Protein Binding | 2 | 2024 | 2224 | 0.050 |
Why?
| | Cell Line | 3 | 2019 | 2847 | 0.050 |
Why?
| | Protein Transport | 1 | 2024 | 445 | 0.050 |
Why?
| | Multigene Family | 2 | 2014 | 198 | 0.050 |
Why?
| | RNA Interference | 2 | 2016 | 469 | 0.050 |
Why?
| | Glioblastoma | 1 | 2006 | 345 | 0.050 |
Why?
| | Substrate Specificity | 2 | 2012 | 372 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 976 | 0.040 |
Why?
| | Introns | 1 | 2019 | 258 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2025 | 3015 | 0.030 |
Why?
| | Prostatic Neoplasms | 1 | 2005 | 1043 | 0.030 |
Why?
| | Radiation, Ionizing | 1 | 2017 | 80 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2006 | 1238 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2010 | 1092 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 332 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 955 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 231 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 293 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2014 | 385 | 0.030 |
Why?
| | Plant Roots | 1 | 2013 | 45 | 0.030 |
Why?
| | Systems Integration | 1 | 2013 | 37 | 0.030 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2013 | 65 | 0.030 |
Why?
| | Genome, Plant | 1 | 2013 | 54 | 0.030 |
Why?
| | Female | 5 | 2025 | 73304 | 0.030 |
Why?
| | Epigenomics | 1 | 2013 | 115 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2013 | 343 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2016 | 365 | 0.020 |
Why?
| | Response Elements | 1 | 2012 | 91 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2012 | 62 | 0.020 |
Why?
| | Cross-Linking Reagents | 1 | 2012 | 217 | 0.020 |
Why?
| | Signal-To-Noise Ratio | 1 | 2011 | 67 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 363 | 0.020 |
Why?
| | Alternative Splicing | 1 | 2013 | 229 | 0.020 |
Why?
| | Macaca | 1 | 2010 | 56 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2011 | 237 | 0.020 |
Why?
| | Operon | 1 | 2010 | 64 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2139 | 0.020 |
Why?
| | Regulon | 1 | 2010 | 36 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 308 | 0.020 |
Why?
| | Eukaryotic Cells | 1 | 2010 | 40 | 0.020 |
Why?
| | Receptors, Death Domain | 1 | 2009 | 3 | 0.020 |
Why?
| | Brain | 2 | 2012 | 2668 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 390 | 0.020 |
Why?
| | Chromatin | 1 | 2013 | 519 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 849 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 404 | 0.020 |
Why?
| | Chemokines | 1 | 2009 | 228 | 0.020 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2007 | 6 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2007 | 25 | 0.020 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2007 | 41 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4149 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2011 | 539 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2008 | 239 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2007 | 185 | 0.020 |
Why?
| | Species Specificity | 1 | 2008 | 585 | 0.020 |
Why?
| | HeLa Cells | 1 | 2008 | 636 | 0.020 |
Why?
| | Receptor, IGF Type 1 | 1 | 2006 | 65 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2006 | 265 | 0.010 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2005 | 49 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3284 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2009 | 617 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 5757 | 0.010 |
Why?
| | Stem Cells | 1 | 2009 | 594 | 0.010 |
Why?
| | Caspases | 1 | 2005 | 247 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2006 | 810 | 0.010 |
Why?
| | Mice, Nude | 1 | 2005 | 698 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 945 | 0.010 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 557 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2005 | 297 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1226 | 0.010 |
Why?
| | ErbB Receptors | 1 | 2006 | 614 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 843 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 847 | 0.010 |
Why?
| | Mutation | 1 | 2012 | 3958 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2009 | 1991 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2008 | 1317 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1783 | 0.010 |
Why?
| | Male | 3 | 2014 | 67762 | 0.010 |
Why?
| | Rats | 1 | 2006 | 5647 | 0.010 |
Why?
| | Apoptosis | 1 | 2005 | 2553 | 0.010 |
Why?
| | Child | 1 | 2012 | 21935 | 0.010 |
Why?
| | Adult | 1 | 2014 | 37929 | 0.010 |
Why?
|
|
Mukherjee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|